FDA Reverses Course and Will Now Review Moderna's Flu Shot
The company's mRNA flu shot, if approved, could be available for the 2026-27 flu season.
----
Nvidia Wins Meta Deal. Its Gain Is Broadcom's Loss.
Nvidia stock has flatlined amid the competitive threat from Broadcom and other chip makers. But Meta Platforms is committing to purchases with the chip maker.
----
DoorDash Expects Ramped Up Spending to Dent First Quarter
The delivery giant expects adjusted EBITDA of $675 million to $775 million due to international investments and further investments in British company Deliveroo.
----
Molson Coors Profit, Sales Fall as Beer Demand Remains Soft
The maker of Blue Moon and Miller High Life said net sales fell 2.7%, to $2.66 billion, compared with analyst estimates of $2.72 billion.
----
Carvana Posts Higher Profit, Revenue on Record Car Sales
The used-car marketplace recorded revenue growing 58%, to $5.6 billion, up from $3.55 billion a year earlier.
----
EBay to Buy Depop From Etsy for $1.2 Billion
EBay Chief Executive Officer Jamie Ianonne said that the addition of Depop to its portfolio would boost its footprint across younger consumers.
----
Booking Sales, Profit Rise as More Travelers Make Reservations
The online travel agency said room nights increased 9% and gross bookings were up 16%.
----
Microsoft Says It Has Reached Its 100% Renewable Electricity Target
Tech giant uses renewable power purchase agreements to offset energy purchases, but critics say it is still burning fossil fuels from the grid.
----
Moody's Posts Higher Profit, Revenue
Moody's logged higher profit and revenue in the fourth quarter, as the company said efforts to scale new technologies across its business were paying off.
----
Glencore Earnings Fall Despite Record Metal Trading Performance
Glencore's metal traders booked record earnings last year amid optimal market conditions, while its energy-trading business suffered as the sector normalized.
----
Johnson & Johnson to Invest More Than $1 Billion in Pennsylvania Cell Therapy Factory
The facility is part of the company's plans to invest $55 billion in U.S. manufacturing, research and development and technology through early 2029.
----
Bayer Shares Reverse Gains After Plan to Settle Roundup Litigation
Shares in the pharmaceutical and agriculture conglomerate fell as much as 10% in European morning trade, wiping out their gains from the previous session, when the stock shot up 7%.
----
MSG Sports Explores Separating Knicks, Rangers
CEO James Dolan said the move would provide each team with greater flexibility and create additional value for shareholders.
----
Jean Paul Gaultier Owner Puig Warns of Slowing Fragrance Market After Strong End to 2025
Madrid-listed shares rose as much as 6.6% after the owner of Jean Paul Gaultier and other brands wrapped up 2025 with climbing sales.
(END) Dow Jones Newswires
February 18, 2026 17:00 ET (22:00 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.